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Abstract
The X-ray crystal structure of the dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase
from Haemophilus influenzae (HiDapE) bound by the products of hydrolysis, succinic acid and l,l-DAP,
was determined at 1.95 Å. Surprisingly, the structure bound to the products revealed that HiDapE
undergoes a significant conformational change in which the catalytic domain rotates ∼50° and shifts
∼10.1 Å (as measured at the position of the Zn atoms) relative to the dimerization domain. This
heretofore unobserved closed conformation revealed significant movements within the catalytic domain
compared to that of wild-type HiDapE, which results in effectively closing off access to the dinuclear 
Zn(II) active site with the succinate carboxylate moiety bridging the dinculear Zn(II) cluster in a μ-1,3 
fashion forming a bis(μ-carboxylato)dizinc(II) core with a Zn–Zn distance of 3.8 Å. Surprisingly, His194.B,
which is located on the dimerization domain of the opposing chain ∼10.1 Å from the dinuclear Zn(II)
active site, forms a hydrogen bond (2.9 Å) with the oxygen atom of succinic acid bound to Zn2, forming 
an oxyanion hole. As the closed structure forms upon substrate binding, the movement of His194.B by
more than ∼10 Å is critical, based on site-directed mutagenesis data, for activation of the scissile
carbonyl carbon of the substrate for nucleophilic attack by a hydroxide nucleophile. Employing 
the HiDapE product-bound structure as the starting point, a reverse engineering approach called
product-based transition-state modeling provided structural models for each major catalytic step. These
data provide insight into the catalytic reaction mechanism and also the future design of new, potent
inhibitors of DapE enzymes.
Antimicrobial therapy has saved millions of lives over the past 80 years, yet our arsenal of effective
antibiotics is increasingly being diminished by the alarming rise of bacteria that are resistant to all
currently available antibiotics.1 More than 2 million people annually in the United States acquire
infections that are resistant to antibiotics, and at least 23000 people die as a result, according to a 
report issued by the Centers for Disease Control and Prevention.2 In the United States, antibiotic
resistance adds $20 billion in additional direct health care costs, with lost productivity adding an
additional $35 billion annually.3 There is an urgent need for antibacterial agents with new cellular
mechanisms of action, underlying the need for research on new antimicrobial targets with previously
unexplored mechanisms of action.4 Themeso-diaminopimelate (mDAP)/lysine biosynthesis pathway
meets these criteria as it represents unexplored yet validated bacterial enzyme targets that are essential 
for bacterial viability but are absent in mammals.
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The dapE-encoded N-succinyl-l,l-diaminopimelic acid desuccinylase (DapE, EC 3.5.1.18) represents a 
promising bacterial enzyme target within the mDAP/lysine biosynthesis pathway that is essential for 
providing lysine and mDAP for bacterial cell wall construction in all Gram-negative and most Gram-
positive bacteria.5 It has been reported that deletion of the dapE gene in Helicobacter
pylori andMycobacterium smegmatis is lethal.6,7 Genes encoding DapE enzymes have been identified in
all pathogenic Gram-negative bacteria, and several DapE enzymes have been biochemically and
structurally characterized from various bacterial sources.8 Of particular interest are the DapEs from the
“ESKAPE” pathogens, which account for >60% of the antibiotic resistant hospital-acquired infections in
the United States.7,9,10 Alignment of the DapE gene from Haemophilus influenzae (HiDapE) with the gene 
sequences of DapEs from “ESKAPE” pathogens reveals at least 49% identity.9 
DapEs hydrolyze N-succinyl-l,l-diaminopimelic acid (l,l-SDAP) to l,l-diaminopimelic acid (l,l-DAP) and
succinate (Figure 1). All DapE enzymes characterized to date are members of the M20 family of
dinuclear Zn(II)-dependent metalloproteases and exist as dimers comprised of a catalytic domain, an
eight-stranded twisted β-sheet that is sandwiched between seven α-helices that contains the catalytic
active site, and a thioredoxin-like dimerization domain.11 The active site is comprised of strictly
conserved residues located on five loops, containing either one or two zinc ions, and is exposed to the
solvent.10 In general, the other members of the M20 family are either monomeric or homodimeric and
appear to have very similar tertiary structures with retention of nearly identical active site Zn(II) ligands.
Of particular interest are the structural features employed by DapE enzymes to hydrolyze l,l-SDAP,
particularly around substrate selectivity,12 with the ultimate goal of designing inhibitors as potential 
antibiotics.
Figure 1. Enzymatic cleavage of l,l-SDAP (1) by DapE yielding succinate (2) and l,l-DAP (3).
To elucidate the structural features critical for DapE enzymes to recognize and bind l,l-SDAP and the
catalytic mechanism of its hydrolysis, we have determined the X-ray crystal structure of [ZnZn(HiDapE)]
bound by the products of hydrolysis, succinic acid and l,l-DAP. The structure of [ZnZn(HiDapE)] bound to
products reveals previously unknown substrate–enzyme interactions and a catalytically significant,
dramatic conformational change, which positions residues from the B subunit in the active site of the A
subunit. In addition, the newly formed amine of l,l-DAP is only 2.9 Å from the newly formed succinic acid
carbon, allowing the use of a new protocol that we term product-based transition-state modeling
(PBTSM)13 to model possible catalytic intermediates. The combination of these data provides new 
insight into substrate recognition and binding as well as the catalytic mechanism of DapE enzymes.5,10 
  
 
 
   
    
 
 
    
     
  
   
     
        
     
      
     
    
    
  
      
     
 
    
       
   
       
    
  
      
      
   
 
       
        
      
      
    
   
   
    
       
Experimental Procedures
Materials
D,L-α,ε-Diaminopimelic acid (98%), succinic anhydride, and ion-exchange resin (Dowex 50WX8-
200,H+ form) were purchased from Sigma. 2-Naphthalenesulfonic acid 1-hydrate (98%) was purchased
from TCI, and microcrystalline cellulose was purchased from Merck. All other chemicals were purchased
from commercial sources and were of the highest quality available.
Protein Expression and Purification
Cloning, expression, and purification of DapE enzymes were performed according to the standard
protocol as described previously for HiDapE11 and the dapE from Neisseria meningitidis(NmDapE).14 The 
cell pellet was thawed, and sonication was used to disrupt the cells. The cell debris was pelleted by
centrifugation at 15000 rpm for 40 min at 4 °C. The supernatant was loaded onto a column packed with
10 mL of HisTrap HP resin (GE Healthcare) and washed with 20 bed volumes of lysis buffer. The His6-
tagged HiDapE enzyme was eluted with 25 mL of elution buffer [500 mM NaCl, 5% glycerol, 50 mM
HEPES (pH 8.0), 250 mM imidazole, and 10 mM 2-mercaptoethanol]. The His6 tag was removed by
treating His6-tagged HiDapE with His6-tagged TEV protease for 16 h at 4 °C in 50 mM HEPES (pH 8.0).
Cleaved protein was concentrated with a Centricon (30000 molecular weight cutoff; Amicon) to 3 mL
and loaded on a HiLoad 16/600 Superdex 200 prep grade column (GE Healthcare) for further 
purification. The resulting solution was mixed with 5 mL of His-Trap HP resin packed on a column to
remove the remaining cleaved His6 tag, uncut protein, and the His6-tagged TEV protease, while the flow-
through containing HiDapE was collected and washed with crystallization buffer [150 mM NaCl, 20 mM
HEPES (pH 8.0), and 1 mM TCEP] and concentrated to ∼20 mg/mL.
Site-Directed Mutagenesis
In the manner previously described,11 the NmDapE site-directed mutant H195A (corresponding to H194
in HiDapE) was introduced on a plasmid carring wild-type (WT) NmDapE using a modified PIPE cloning 
procedure (PMID:21185308). Briefly, the following primers were used to amplify the dapE gene
encoding NmDapE (H195A-F, CAA GCA AGG CGC TAT TGC CTA TCC GCA TTT GGC AAT CAA TC)
and NmDapE (H195A-R, TAG GCA ATA GCG CCT TGC TTG CCT TTG ACG GTC A). The unpurified product of 
amplification was treated with T4 polymerase and transformed to chemically competent BL21-Gold 
(DE3) cells. The presence of both mutations was confirmed by sequencing at University of Chicago
Cancer Research DNA Sequencing Facility. Purification of the NmDapE H195A mutant enzyme was
conducted as described above for HiDapE.
Enzymatic Assay
SDAP was synthesized using the procedure described by Lin et al.,15 providing an overall yield of 41%.
The specific activities of all HiDapE and NmDapE proteins were determined using a 50/50 mixture of D,D-
and L,L-SDAP as the substrate in 50 mM phosphate buffer (PPi) or 50 mM HEPES (pH 7.5), as previously
described.12 The kinetic parameters Vmax and Km were determined by quantifying amide bond cleavage
(decrease in absorbance) of L,L-SDAP at 225 nm (ε = 698 M–1cm–1) in triplicate using a Shimadzu UV-2450
spectrophotometer equipped with a temperature controller. Enzyme activities are expressed in units
per milligram, where 1 unit is defined as the amount of enzyme that releases 1 μmol of L,L-SDAP at 30 °C
in 1 min. Catalytic activities were determined with an error of ±10%. Initial rates were fit directly to the
Michaelis–Menten equation to obtain the catalytic constants Km and kcat using Origin software.
 
          
  
    
   
      
     
          
    
     
   
 
  
 
  
  
  
  
     
 
   
   
   
   
    
    
      
 
     
  
  
  
  
Crystallization
Prior to crystallization, 50 mM L,L-SDAP was added to HiDapE and equilibrated on ice for 30 min. Almost
300 commercially available conditions were used for screening by the sitting-drop vapor-diffusion
method at 16 °C using a Mosquito liquid handling robot with 96-well plates. Crystals were observed
under 10 different conditions within 3 weeks. The best crystals were obtained using 400 nL of a
precipitant solution [0.05 M HEPES (pH 7.3), 10.7% (w/v) PEG MME 2000, and 8.6% (w/v) PEG 2000] and
400 nL of an 18 mg/mL solution of HiDapE. The crystals belonged to orthorhombic space group I222 with
one molecule in the asymmetric unit and the following unit cell parameters: a = 56.6 Å, b = 135.5 Å, c = 
149.6 Å, and α = β = γ = 90° (Table 1). HiDapE is a dimer, and the protein 2-fold axis coincides with the
crystallographic axis. Prior to data collection, the mother liquid, containing 25% glycerol, was used as a 
cryoprotectant. The crystal was retrieved with a nylon loop (Molecular Dimensions) and flash-frozen in
liquid nitrogen.
Table 1. Data Collection and Refinement Statisticsa
Data Collection
beamline SBC19-ID (APS)
wavelength (Å) 0.9794
resolution range (Å) 33.48–1.95 (2.02–1.95)
space group I222
unit cell 56.65 Å, 135.54 Å, 149.61 Å, 90°,
90°, 90°
total no. of reflections 41902
no. of unique reflections 38497 (2564)
multiplicity 4.0 (3.2)
completeness (%) 0.995 (0.997)
mean I/σ(I) 16.25 (2.15)
Wilson B factor 18.02
Rmerge, Rmeas 0.10 (0.81), 0.11 (0. 95)
Refinement
Rwork, Rfree 0.162 (0.179), 0.184 (0.204)
bonds (Å)/angles (deg) 0.008/1.174
no. of non-hydrogen atoms 3191
macromolecules 2936
ligands 23
  
 
 
 
 
 
 
  
   
  
  
    
  
   
  
      
   
     
    
    
       
    
     
    
    
       
    
   
 
 
  
     
 
   
      
   
   
    
       
 
protein residues 384
root-mean-square deviation for bonds
(Å)
0.008
root-mean-square deviation for angles
(deg)
1.13
Ramachandran favored/allowed (%) 98/2.1
Ramachandran outliers (%) 0
rotamer outliers (%) 2.2
Clashscore 0.85
average B factor (Å2) 25.99
molecule/ligands/solvent (Å2) 25.66/20.39/30.69
a Statistics for the highest-resolution shell are shown in parentheses.
Structure Determination
The presence of Zn ions in the protein crystals of HiDapE was confirmed by X-ray fluorescence
spectroscopy. Data were collected on the 19-ID beamline of the Structural Biology Center at the
Advanced Photon Source using SBC-Collect software at a wavelength of 0.9795 Å from the single crystal,
and the data were processed using HKL3000.16 Crystallographic parameters are summarized in Table 1. 
The structure of the complex of HiDapE was determined by molecular replacement using the catalytic
and dimerization domains separately [Protein Data Bank (PDB) entries 4H2K and 3ISZ, respectively] as
search models.10,11 Molecular replacement searches were completed using MOLREP of the CCP4
suite.17 The initial model was adjusted manually and refined using programs REFMAC XX18 and
Phenix.19 The final models were refined against all reflections except for 5% randomly selected
reflections, which were used to monitor Rfree. The final rounds of refinement were performed using TLS
refinement with three TLS groups, and the final refinement statistics are listed in Table 1. Analysis and
validation of the structures were performed with the aid of MOLPROBITY and COOT validation
tools.20,21 Figures were prepared using Pymol and the Chemical Computing Group’s Molecular Operating
Environment (MOE).22 
Protein Data Bank Entry
The atomic coordinates and structure factor file for the [ZnZn(HiDapE)] product-bound structure have
been deposited in the RCSB Protein Data Bank as entry 5VO3.
Chemical Modification Reagents
The arginine-specific chemical modification reagent, 2,3-butanedione, was tested as an inhibitor
of HiDapE. A 1.0 M 2,3-butanedione solution was prepared in 50 mM borate buffer (pH 7.8) and added
to 1 μM HiDapE in the dark in 50 mM borate buffer (pH 7.8) to provide final 2,3-butanedione
concentrations of 0, 10, 20, 40, and 80 mM. Because it is possible for 2,3-butanedione to act as a
photosensitizing agent and cause the modification of other residues, the experiments were performed
in triplicate in the dark to verify that the loss of DapE activity was the result of the modification of 
arginine residues. Similarly, the lysine-specific reagent, 2,4,6-trinitrobenzene sulfonate, was also shown
      
   
 
   
     
 
   
 
    
      
  
 
  
    
    
      
   
   
  
  
 
   
    
  
 
    
     
    
   
       
     
 
to inhibit the hydrolysis of l,l-SDAP by HiDapE in 50 mM phosphate buffer (pH 7.8) at 25 °C. The
concentrations of 2,4,6-trinitrobenzene sulfonate used were 0, 2.5, 10, and 20 mM.
In Silico Modeling
Product-based transition-state modeling (PBTSM)13 was performed using the Chemical Computing
Group’s MOE.22 The HiDapE product-bound crystal structure (PDB entry 5VO3) was used as the starting
point for PBTSM. The crystallographic data were prepared using MOE’s utility structure-prep to correct 
for any artifacts.22 The model was then solvated in a simple box of water at pH 7.4 that contained NaCl 
counterions for charge balance. Periodic boundary conditions were enabled, and the hydrogen bonding 
network of the model was optimized by sampling different tautomer/protomer states using
Protonate3D.23 A localized energy minimization was run on the solvated system using the MOE function
QuickPrep, followed by a short global minimization to equilibrate the system. Product atom coordinates
were used to model the tetrahedral transition state and the subsequent substrate catalytic hydroxyl-
bound structure, and the substrate binding step. In each case, the hydrogen bonding network and
formal charges were optimized so the overall net charge of the system remained balanced. A localized
minimization was conducted for each intermediate to normalize the bond distances and angles followed
by a 1.0 ns molecular dynamics (MD) equilibration using an NPA algorithm with an Amber12:EHT force
field. MD experiments utilized an initial heating from 0 to 300 K over 100 ps followed by equilibration for
100 ps at 300 K, after which a 700 ps production run was performed. Finally, a 100 ps cooling from 300
to 0 K was performed.
Results and Discussion
Conformational Change upon Substrate Binding
DapE enzymes have strict specificity for the l,l-isoform of SDAP, and this specificity is built into the active
site, which includes both the dinuclear metal cluster and adjacent amino acid residues.24 A well-defined
and negatively charged, crescent-shaped cavity was previously identified in the [ZnZn(HiDapE)]
structure.5,10 Considering the linear character of the substrate, it was hypothesized that the substrate 
binds in this crescent-shaped cavity lining up along the groove with the peptide bond positioned over
the active site metal ions; however, the exact binding conformation of l,l-SDAP is unknown. In the WT
[ZnZn(HiDapE)] structure, the catalytic and dimerization domains adopt an extended conformation with
dimensions of 50 Å × 44 Å × 121 Å with the crescent-shaped cavity located between the two domains.
The center of the catalytic domain that coordinates the metal ions is broadly open, allowing substrate
access to the dinuclear Zn(II) active site (Figure 2A).10 Substrate poses developed by docking l,l-SDAP
along this groove positioned the substrate carbonyl carbon near Zn1.
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Figure 2. Side-by-side comparison of structures of HiDapE in two different conformations. (A) Ribbon
diagram of the previously reported holoenzyme structure of HiDapE in its “open” conformation (PDB
entry 3IC1). (B) Structure of the complex of HiDapE with the products succinic acid (magenta) and l-
diaminopimelic acid (yellow), in the closed conformation. Individual subunits of the homodimer are
colored green and orange. Panels C and D show the complexity of the domain movements for HiDapE.
(C) Extent of rotational conformational changes as observed by superimposition of the catalytic domains
of the monomers of open (gray) and closed (orange) structures. (D) Movement within the dimerization
and catalytic domains as revealed by superimposition of the dimerization domains of the open and
closed conformation structures.
The addition of l,l-SDAP to [ZnZn(HiDapE)], prior to crystallization, yielded orthorhombic crystals found
to exhibit a space group (I222) that is different from that of WT [ZnZn(HiDapE)] (P212121), which
diffracted to 1.95 Å. The structure that emerged revealed [ZnZn(HiDapE)] bound by the products of
hydrolysis, succinic acid and l,l-DAP, which are clearly observed in the 2Fo – Fc omit maps (Figure 3A). 
Surprisingly, the structure bound to products revealed that the HiDapE enzyme had undergone a
significant conformational change that shrinks the enzyme in size with overall dimensions of 47 Å × 45 Å
× 111 Å (Figure 2B). An overlay of the open WT [ZnZn(HiDapE)] structure with the closed [ZnZn(HiDapE)]
structure bound to products reveals that in the conformation bound to products, the catalytic domain
rotates ∼50° and shifts as much as 29 Å at the exterior of the protein and 10 Å at the protein center of 
the catalytic domains (as measured at the position of the Zn atoms) (Figure 2C,D). This heretofore
unobserved closed conformation revealed significant movements within the catalytic domain compared
to [ZnZn(HiDapE)], which results in effectively closing off access to the dinuclear Zn(II) active site (Figure
S1). Moreover, several new protein–ligand interactions, which had not previously been observed or
predicted by either docking attempts or molecular dynamics studies conducted on the open, WT
[ZnZn(HiDapE)] structure, are revealed. These data also disclose the surprisingly flexible nature of the
DapE active site.25 
       
      
   
    
 
 
    
   
   
  
   
  
     
      
  
     
    
     
 
  
   
      
     
     
  
 
   
     
 
     
 
Figure 3. Close-up of HiDapE bound by the products of l,l-SDAP hydrolysis, succinic acid (cyan) and l-
diaminopimelic acid (yellow), and the interacting side chains and zinc ions. (A) Fo – Fc omit map of the
products at 3.5σ. (B) The side chains are colored orange or green to highlight the contribution of
residues in both subunits of the homodimer. Residues interacting with succinic acid and l,l-DAP are
highlighted in cyan and yellow boxes, respectively.
The closed [ZnZn(HiDapE)] structure bound to products illustrates that the substrate binding pocket can
be divided into succinic acid and l,l-DAP binding regions (Figure 3A), with the succinic acid binding 
pocket positioned adjacent to the dinuclear Zn(II) active site, as highlighted by the cyan box in Figure 3B. 
The succinate carboxylate group bound to the dinuclear Zn(II) cluster exhibits Zn–O atom bond distances
of 1.9 Å (Zn1–O1), 2.5 Å (Zn2–O1), 4.1 Å (Zn1–O2), and 2.1 Å (Zn2–O2). The Zn2–O1 bond distance of 2.5
A is too long for a covalent bonding interaction, as the average Zn–O(carboxylate) bond distance in
proteins is 2.01 Å and is at the limit of their van der Waals radii.26 Therefore, the succinate carboxylate
moiety bridges the dinculear Zn(II) cluster in a μ-1,3 fashion forming a bis(μ-carboxylato)dizinc(II) core
with a Zn–Zn distance of 3.8 Å (Figures 3A and 5A). Both Zn(II) ions reside in distorted tetrahedral or 
trigonal bipyramidal (TBP) geometries, with the oxygen atom of Asp100 (2.0 Å) and the dangling oxygen
atom of Glu163 (2.6 Å) making up the axial positions of a potential TBP geometry for Zn1 and the oxygen
atom of Asp100 (1.9 Å) and the dangling oxygen atom of Glu135.A (2.4 Å) making up the axial positions
of a potential TBP geometry for Zn2.
The other carboxylate group of the succinic acid moiety forms a salt bridge with the ammonium groups
of Arg178.A (2.9 and 3.1 Å) and an H-bonding interaction between the O1 atom and aromatic hydroxyl
hydrogen of Tyr197.B (2.4 Å), from the opposing dimerization domain. Moreover, a water molecule is
observed bridging the O2 atom of succinic acid (2.8 Å) and the N atom of the ammonium group of
Lys175.A (3.0 Å). Given this interaction, we examined the ability of the Lys-specific reagent, 2,4,6-
trinitrobenzene sulfonate, which forms a stable covalent complex with free amines, to inhibit
[ZnZn(HiDapE)]. Upon incubation of [ZnZn(HiDapE)] with 2,4,6-trinitrobenzene sulfonate, the enzyme 
quickly loses catalytic activity in a time- and 2,4,6-trinitrobenzene sulfonate concentration-dependent
fashion (Figure S2B). These data suggest that at least one Lys residue is involved in substrate binding,
consistent with the [ZnZn(HiDapE)] structure bound to products. The observed interactions of 
[ZnZn(HiDapE)] with succinic acid echo some of the interactions observed in the DapE–captopril inhibitor
complex.14 
    
  
     
    
   
  
  
    
    
   
  
     
   
    
   
   
   
      
    
   
      
     
    
 
 
     
     
   
   
     
    
   
    
  
  
l,l-DAP, on the other hand, does not bind to the dinuclear center but interacts solely through contacts
between its carboxylate groups and the enzyme side chains Asn244.B, Asn245.B, Ser181.A, Ser290.A,
and Arg258.A as shown in the yellow box in Figure 3B. It is noteworthy that nearly all of these residues
are strictly conserved in DapE enzymes.24 Additional evidence that an Arg residue interacts with
substrate was obtained with the arginine-specific chemical modification reagent, 2,3-butanedione. Upon
the addition of 2,3-butanedione to [ZnZn(HiDapE)], catalytic activity is lost in a time- and inhibitor
concentration-dependent fashion, indicating that at least one arginine residue interacts with the 
substrate (Figure S2A). As confirmed by the [ZnZn(HiDapE)] structure bound to products, the terminal l,l-
DAP carboxyl group forms hydrogen bonding interactions with one arginine residue, Arg258.A, which is
located near the hinge region of DapE. Consequently, this hydrogen bonding interation, along with those
for Asn244.B and Asn245.B, likely drives the open HiDapE conformation to close in combination with
Coulombic interactions via the succinic acid portion of the substrate with Tyr197.B and His194.B.
Therefore, binding of the substrate induces the dimer superstructure to flex and twist at the hinge
region, resulting in dynamic modulation during catalysis. Initially, this dynamic modulation occurs to
accommodate the substrate in the active site and then to position active site residues, including those 
from the dimerization domain of the opposite chain, for catalytic turnover. The overall characteristic of 
this closure movement is consistent with a hinge domain movement mechanism,27-29 which allows a
twist and turn movement of the interdomain linker.
Surprisingly, His194.B, which is located on the dimerization domain of the opposing chain ∼10.1 Å from
the dinuclear Zn(II) active site in the WT structure (Figure 4A), forms a hydrogen bond (2.9 Å) with the
oxygen atom of succinic acid bound to Zn2 in the [ZnZn(HiDapE)] structure bound to products
(Figure 4B). This results in the formation of an oxyanion hole consisting of Zn(II) and His194.B that forms
in the closed structure. As the closed structure forms upon substrate binding, the movement of His194.B
by >10 Å is critical as it assists in activating the scissile carbonyl carbon of the substrate for nucleophilic
attack by a hydroxide nucleophile and also helps to stabilize the transition state. The concept of an
oxyanion hole is a well-established enzyme characteristic in biochemistry, specifically when referring to
serine or serine-like hydrolase/peptidase enzymatic functions.30,31 As HiDapE exhibits >60% of its
maximal activity when only one Zn(II) ion is present on the Zn1 side of the dinuclear active site, His194.B 
likely plays a crucial role in activating the carbonyl carbon of l,l-SDAP in the absence of Zn2, possibly
forming an oxyanion hole with the Zn2 ligand His349.A. Sequence alignment with multiple
DapE’s32 (Figure S3) confirms that H194 in HiDapE is highly conserved. Mutation of His195.B 
in NmDapE,14 which corresponds to H194.B in HiDapE, provides a [ZnZn(NmDapE)] enzyme that exhibits
only ∼3% of its WT activity. These data indicate that H194.B is critical for catalytic activity in the
presence of two Zn(II) ions but not essential. Therefore, the [ZnZn(HiDapE)] structure bound to products
demonstrates that residues residing in both domains play key roles in catalysis, and significantly, residue
His194.B of HiDapE had not previously been identified as a catalytically important residue.
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Figure 4. (A) HiDapE open conformation showing the distal location of H194.B. (B) Proposed oxyanion
hole formed by H194.B and Zn2 in the catalytically active closed form of HiDapE.
Modeling the DapE Catalytic Reaction
Our recently reported product-based transition-state modeling (PBTSM) method13 was employed, using 
the [ZnZn(HiDapE)] product-bound structure as a starting point structure (Figure 5A,B).13 PBTSM is a
reverse engineering approach that provides catalytic models for the lowest-energy structures of each
major catalytic step, using a combination of molecular mechanics and molecular dynamics in reverse
chronological order. This modeling technique was performed using the Chemical Computing Group’s
MOE modeling suite.22 The [ZnZn(HiDapE)] product-bound structure atom coordinates were used to
model the tetrahedral transition-state complex, which reflects the moment immediately after
nucleophilic attack by a hydroxyl group at the amide carbonyl carbon of the substrate (Figure 6A,B). In
the [ZnZn(HiDapE)] products-bound structure, the scissile carbonyl carbon is 2.9 Å from the ammonium
nitrogen of l,l-DAP (Figure 5B), allowing for the re-formation of an amide bond using the Builder utility in
MOE, creating a distorted tetrahedral intermediate complex. Application of the correct formal charges
for the ammonium nitrogen and the alkoxide oxygen associated with the amide carbonyl of the
substrate was followed by hydrogen bond network optimization. These critical system adjustments
notably affected the ionization states and hydrogen bonding interactions of Glu134.A, which was
previously shown to function as the general acid/base.24 A local minimization was conducted to
normalize the bond distances and angles of the l,l-SDAP-OH tetrahedral intermediate as well as balance
the net charges of the ligand/receptor system, after which a 1.0 ns molecular dynamics equilibration
was performed using an NPA algorithm with an Amber12:EHT force field.33,34 
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Figure 5. (A) Radial and (B) axial views of HiDapE’s binding pocket with succinate acid and l,l-DAP bound
in the closed conformation, generated from the crystal structure (PDB entry) utilizing the PBTSM
protocol. Succinate and l,l-DAP are colored cyan and yellow, respectively, while protein chains A and B
are colored dark green and orange, respectively. The Zn(II) ions are shown as black spheres and waters
as red spheres; amino groups are colored dark blue and red for nitrogen and oxygen, respectively.
Figure 6. PBTSM-generated models showing the (A) radial and (B) axial views of HiDapE’s bindng pocket
with the l,l-SDAP transition-state complex bound in the closed conformation. The color scheme is
identical to that in Figure 5.
The model developed for the tetrahedral intermediate based on the [ZnZn(HiDapE)] structure bound to
products reveals several interesting aspects of the catalytic mechanism (Figure 6A,B). First, an increase
in the Zn–Zn distance from 3.8 to 4.0 Å was observed along with improvement in the hydrogen bond
network. Because HiDapE exhibits >60% of its maximal activity when a single Zn(II) ion bound on the Zn1
side of the dinuclear active site,10 the O1 atom of the modeled transition-state complex bound to Zn1
represents the hydroxide oxygen atom while the O2 atom bound to Zn2 is due to the substrate carbonyl
carbon (Figure 6A). The increase in Zn–Zn distance also increases the O1–Zn2 distance to >2.6 Å, which
reinforces the proposal that the nucleophilic hydroxide is bound to and delivered by Zn1. The
combination of His194.B retaining a strong hydrogen bonding interaction with O2 along with
coordination of O2 to Zn2 is consistent with this being an alkoxide moiety derived from the substrate
carbonyl group. This model also reveals that Glu134.A forms hydrogen bonds to both the succinc acid
     
 
  
   
  
  
   
  
   
    
     
 
     
    
   
    
   
   
   
      
   
    
  
   
 
    
    
     
     
    
    
  
   
     
   
   
O1 atom and the l,l-DAP amide nitrogen atom, consistent with its proposed role as a general
acid/base.24 
Interestingly, a single oxygen atom bridge does not exist between the two active site Zn(II) ions. This
finding is in contrast to Zn K-edge EXAFS spectra of [ZnZn(HiDapE)] in the presence of the competitive,
transition-state analogue inhibitor 2-carboxyethylphosphonic acid (CEPA), which indicated that the Zn– 
Zn distance remained unchanged at 3.34 Å.35 The fact that the Zn–Zn distance does not change upon
binding of CEPA to [ZnZn(HiDapE)] suggests an η-1-μ-phosphonate bridge exists, similar to the mode of 
binding of leucine phosphonic acid to the leucine aminopeptidase from bovine lens.36 As this is clearly
not the case for the actual substrate transition-state complex for [ZnZn(HiDapE)] based on the PBTSM
transition-state model and the [ZnZn(HiDapE)] structure bound to products, the difference is likely due
to the heretofore previously unknown open and closed conformations of DapE. CEPA would not interact
with the residues located near the hinge region of DapE, such as Asn244.B and Arg258.A, which likely
drive the formation of the closed structure and clearly form hydrogen bonding interations with the
substrate functional groups in the tetrahedral (transition-state) complex (Figure 6B) and the
[ZnZn(HiDapE)] structure bound to products (Figure 5B). These data emphasize the importance of the
newly discovered closed structure and its impact not only on the catalytic reaction mechanism but also
on the future design of new, potent inhibitors of DapE enzymes.
Using the transition-state model derived from the [ZnZn(HiDapE)] structure bound to products, the
atomic coordinates for the catalytic hydroxyl group and native substrate bound to [ZnZn(HiDapE)] were
calculated. This model reflects the moment just after deprotonation of the catalytic water by the
general acid/base, Glu134.A, but just before nucleophilic attack by the activated hydroxyl group at the
substrate amide carbonyl. MOE’s Builder utility was utilized to remove the bond between the
tetrahedral carbonyl carbon and the O1 atom, the oxygen bound to Zn1. An ionization-state adjustment 
of the newly formed catalytic water/hydroxide oxygen to a negative form (O––C···X···OH to O––C –OH) is
also required. Thus, the catalytic hydroxyl group, coordinated to Zn1, was modeled into the system in
the approximate area observed in other known crystal structures of DapE.10,11,14 Next, a double bond
was created, re-forming the substrate carbonyl moiety (O––C–NH to O═C–NH). As with the tetrahedral
intermediate model, a local minimization was initiated to correct bond angles and distances, after which
a 1.0 ns molecular dynamics equilibration was performed (Figure 7A,B). This model reveals that the 
nucleophilic hydroxide is located on Zn1 while the substrate carbonyl oxygen atom is coordinated to
Zn2, with His194.B forming a hydrogen bond to the O2 carbonyl atom. This oxyanion hole activates the
scissile carbonyl carbon for nucleophilic attack. The closed, crescent-shaped substrate binding pocket
positions the scissile carbonyl carbon above the hydroxide moiety bound to Zn1 (2.9 Å), preorganizing
the substrate for nucleophilic attack. This model clearly shows the role of both Zn(II) ions in catalysis and
reinforces the importance of substrate hydrogen bonding interactions with Arg, Asn, and Lys residues in
subunit A and near the hinge region of subunit B.
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Figure 7. PBTSM-generated models showing the (A) radial and (B) axial views of HiDapE’s bindng pocket
with l,l-SDAP and the activated catalytic hydroxyl group bound in the closed conformation. The color
scheme is identical to that in Figure 5.
Finally, PBTSM was applied to the catalytic hydroxyl group and native substrate-bound [ZnZn(HiDapE)]
model to estimate the atomic coordinates of the initial step of binding of the substrate to
[ZnZn(HiDapE)]. This model reflects the moment just after substrate binding and the displacement of the 
bridging water molecule observed in the WT [ZnZn(HiDapE)] structure and subsequent conformational
closure of the active site. This model’s point in time also falls just before deprotonation of the catalytic
water by Glu134.A. The model was generated by deprotonating Glu134.A along with the simultaneous
protonation of the catalytic hydroxyl group and the formation of an O1–Zn2 bonding interaction.
Protonate3D was used followed by QuickPrep to reoptimize the hydrogen bonding network. A localized
energy minimization step was then applied to the system followed by a 1.0 ns molecular dynamics
equilibration (Figure 8A,B). This model contains a (μ-aquo)(μ-carboxylato)dizinc(II) core with a Zn–Zn 
distance of 3.4 Å with one terminal carboxylate and one histidine residue at each metal site (Figure 8A). 
The amide carbonyl of l,l-SDAP is positioned near Zn2, while the amide N–H acts as a hydrogen bond
donor to the backbone carbonyl of Thr325.A, a residue that was previously implicated as being 
catalytically important.37 In addition, His194.B moves into the active site and forms an oxyanion hole
along with Zn2, via a strong hydrogen bonding interaction with the amide carbonyl oxygen, O2. The
proximal carboxylate of l,l-SDAP participates in bifurcated hydrogen bonds with side chains Arg258.A,
Thr325.A, and Asn245.B (Figure 8B). The free primary amino group acts as a hydrogen bond donor to the
backbone carbonyl of Ala136.A and a water molecule, which in turn participates in the donation of a
hydrogen bond to the backbone carbonyl of Glu135.A and the side chain carbonyl of Asn245.B. The
terminal carboxylate of the pimelic acid moiety is hydrogen bonded to the N–H group of Asn244.B, the
side chain hydroxyl of Ser181.A and Ser290.A, and a water molecule, which in turn forms an H-bond to
the side chain hydroxyls of Thr183.A and Thr325.A.
      
     
   
 
 
  
   
  
     
    
    
     
 
       
    
  
   
  
   
      
 
     
     
   
 
    
    
    
Figure 8. PBTSM-generated models showing the (A) radial and (B) axial views of HiDapE’s bindng pocket
with l,l-SDAP and the unactivated catalytic water bound in the closed conformation. The color scheme is
identical to that in Figure 5.
Implications for the Catalytic Mechanism of DapE
The [ZnZn(HiDapE)] product-bound structure and modeling studies described herein enable further
refinement of the previously proposed catalytic mechanism for DapE enzymes to include the important 
catalytic roles played by dimerization domain residues in the recognition and binding of the substrate
and activation of the amide carbonyl (Figure 9).5 Combination of the data presented herein along with
all the available DapE structures and the previously reported kinetic and spectroscopic data38 suggests 
that the first step in catalysis for DapEs is the recognition of l,l-SDAP by the crescent-shaped cavity
adjacent to the dinuclear Zn(II) cluster with the enzyme in the open conformation. Substrate binding 
induces a conformational change, resulting in the closed DapE structure, that positions the amide
carbonyl oxygen, O2, of l,l-SDAP adjacent to Zn2 and triggers the formation of an oxyanion hole by
shifting His194.B from the dimerization domain of the B protein strand into the active site. Formation of 
a strong hydrogen bond between His194.B and the amide carbonyl oxygen atom facilitates coordination
to Zn2, thus displacing the bridging water molecule onto Zn1 and activating the scissile carbonyl carbon
for nucleophilic attack. Deprotonation of the Zn1-bound water molecule by Glu134.A forms a
nucleophilic hydroxide moiety, consistent with the postulated pKa of the Zn(II)-bound water
molecule.24 Once the Zn1-bound hydroxide is formed, it can attack the activated carbonyl carbon of the
substrate, forming an η-1,3-μ-tetrahedral transition-state complex. Solvent kinetic isotope effect studies
yielded an inverse isotope effect that was explained by the attack of a Zn(II)-bound hydroxide on the
amide carbonyl.24 As observed for similar M20 metalloenzymes, such as the aminopeptidase
from Aeromonas proterlytica (AAP), and further confirmed by the [ZnZn(HiDapE)] product-bound
structure, Glu134.A provides a proton to the penultimate amino nitrogen, returning it to its ionized
state. Upon cleavage of the amide bond, the tethering interaction of the products that maintains the 
closed enzyme conformation is disrupted. Release of the products is entropy-driven, facilitating re-
formation of the open DapE conformation with the addition of a bridging water molecule.
      
     
  
       
  
    
  
    
 
   
  
   
    
   
 
     
       
     
    
      
    
           
     
         
  
      
Figure 9. Proposed catalytic mechanism for the hydrolysis of l,l-SDAP by DapE enzymes.
In the absence of Zn2, the catalytic mechanism is not expected to markedly change as substrate binding 
will still likely induce the formation of the closed conformation moving His194.B into the active stite,
likely forming an oxyanion hole with the Zn2 ligand His349.A. This oxyanion hole would activate the
amide carbonyl, allowing for nucleophilic attack by the Zn1-bound hydroxide. The remaining steps in the
mechanism would be the same as that proposed for the dinuclear Zn(II) enzyme, except that His349.A
and His194.B would function to stabilize the tetrahedral transion state, analogous to that proposed for
39-41 the monometalated forms of AAP and the methionine aminopeptidase from Escherichia coli. 
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